A Trial of Antiparasitic Treatment to Reduce the Rate of Seizures Due to Cerebral Cysticercosis
Author(s) -
Héctor H. Garcı́a,
E. Javier Pretell,
Robert H. Gilman,
Santiago Martínez,
Lawrence H. Moulton,
Óscar H. Del Brutto,
Genaro Herrera,
Carlton A. Evans,
Armando E. González
Publication year - 2004
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa031294
Subject(s) - neurocysticercosis , medicine , cysticercosis , antiparasitic agent , antiparasitic , epilepsy , intensive care medicine , helminthiasis , taenia solium , pediatrics , anesthesia , pharmacology , psychiatry , immunology , pathology
Neurocysticercosis is the main cause of adult-onset seizures in the developing world. Whether therapy with antiparasitic agents results in improved seizure control has been questioned because of the lack of adequate, controlled studies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom